Latest news with #BenHendrix


Business Insider
22-07-2025
- Business
- Business Insider
RBC Capital Reaffirms Their Buy Rating on Elevance Health (ELV)
RBC Capital analyst Ben Hendrix maintained a Buy rating on Elevance Health yesterday and set a price target of $311.00. The company's shares closed yesterday at $276.45. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Hendrix covers the Healthcare sector, focusing on stocks such as Cigna, Elevance Health, and HCA Healthcare. According to TipRanks, Hendrix has an average return of 1.6% and a 46.08% success rate on recommended stocks. In addition to RBC Capital, Elevance Health also received a Buy from Bernstein's Lance Wilkes in a report issued yesterday. However, on the same day, Argus Research downgraded Elevance Health (NYSE: ELV) to a Hold. Based on Elevance Health's latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $60.04 billion and a net profit of $2.28 billion. In comparison, last year the company earned a revenue of $43.65 billion and had a net profit of $2.3 billion Based on the recent corporate insider activity of 38 insiders, corporate insider sentiment is neutral on the stock. Most recently, in April 2025, Mark Kaye, the EVP & CFO of ELV sold 4,588.00 shares for a total of $1,949,074.16.


Business Insider
16-07-2025
- Business
- Business Insider
RBC Capital Remains a Buy on HCA Healthcare (HCA)
RBC Capital analyst Ben Hendrix maintained a Buy rating on HCA Healthcare on July 14 and set a price target of $404.00. The company's shares closed yesterday at $371.80. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Hendrix covers the Healthcare sector, focusing on stocks such as Cigna, HCA Healthcare, and Humana. According to TipRanks, Hendrix has an average return of 3.2% and a 48.41% success rate on recommended stocks. HCA Healthcare has an analyst consensus of Moderate Buy, with a price target consensus of $395.33, implying a 6.33% upside from current levels. In a report released on July 10, Barclays also maintained a Buy rating on the stock with a $416.00 price target. The company has a one-year high of $417.14 and a one-year low of $289.98. Currently, HCA Healthcare has an average volume of 1.47M. Based on the recent corporate insider activity of 59 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of HCA in relation to earlier this year. Most recently, in May 2025, Jon Foster, the EVP & COO of HCA sold 15,698.00 shares for a total of $5,797,585.36.
Yahoo
11-07-2025
- Business
- Yahoo
RBC Capital Maintains a Buy on Brookdale Senior Living (BKD) With a $9 PT
Brookdale Senior Living Inc. (NYSE:BKD) is one of the 13 Best Healthcare Stocks to Buy Under $10. In a report released on July 8, Ben Hendrix from RBC Capital maintained a Buy rating on Brookdale Senior Living Inc. (NYSE:BKD) with a price target of $9.00. A supportive smile shared between a care facility staff member and a resident with Alzheimer's or Dementia. In its June report, Brookdale Senior Living Inc. (NYSE:BKD) reported a notable improvement in its occupancy rates for the month, with a weighted average occupancy of 80.5%. This marks a rise of 230 basis points year-over-year and 50 basis points sequentially. The company also reported that the month-end consolidated occupancy reached 82.2%, suggesting effective sales execution and strong demand. These trends highlight the company's standing in the senior living industry. Brookdale Senior Living Inc. (NYSE:BKD) operates senior living communities. The company focuses on assisted living, dementia-care communities, independent living, and continuing care retirement centers. Its operations are divided into the Independent Living, Assisted Living and Memory Care, and CCRCs segments. While we acknowledge the potential of BKD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
03-07-2025
- Business
- Yahoo
RBC Sees Limited Exposure to Medicaid Risks for Tenet (THC), Reiterated $189 Target
Tenet Healthcare Corporation (NYSE:THC) is one of the 20 undervalued momentum stocks that are taking off. On June 11, RBC Capital analyst Ben Hendrix reiterated a Buy rating on Tenet Healthcare (THC), maintaining a price target of $189. The reaffirmation follows recent volatility in hospital stocks triggered by a White House memo regarding Medicaid supplemental payment programs. While the memo raised concerns, particularly around potential reductions in state-directed payments, Hendrix views the market reaction as overdone. He notes that the language in the memo aligns with that in the current budget bill that allow for the continuation, or 'grandfathering,' of existing programs. Therefore, in his view, the memo does not introduce any new or material headwinds for hospital earnings. A successful healthcare provider smiling confidently in a modern hospital facility. Hendrix sees the pullback in hospital names as a buying opportunity, especially for acute care providers like HCA Healthcare, Community Health, Ardent Health, and, notably, Tenet. He believes Tenet is well-positioned due to its relatively lower exposure to the Medicaid-directed payment programs that have come under scrutiny. This could help the company remain insulated, and do relatively better compared to its peers. Therefore, Tenet remains the analyst's top pick in the hospital sector. He believes that the recent weakness in the stock offers a more attractive entry point for long-term investors. Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company that operates a nationwide care delivery network, including ambulatory surgery centers, surgical hospitals, and a national portfolio of acute care and specialty hospitals. While we acknowledge the potential of THC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and 10 Best Tech Stocks to Buy According to Billionaires. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
24-06-2025
- Business
- Yahoo
HCA Healthcare price target raised to $404 from $376 at RBC Capital
RBC Capital analyst Ben Hendrix raised the firm's price target on HCA Healthcare (HCA) to $404 from $376 and keeps an Outperform rating on the shares after meeting with its management team. The firm has left the meetings incrementally more confident in HCA's positioning for healthcare policy changes thanks to resiliency efforts, which should help soften Medicaid provisions in the Senate's latest bill, the analyst tells investors in a research note. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders' Hot Stocks on TipRanks >> Disclaimer & DisclosureReport an Issue Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data